Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder.
about
Economic evaluation in the field of mental health: conceptual basisA decision analysis of long-term lithium treatment and the risk of renal failureAssociation between duration of untreated bipolar disorder and clinical outcome: data from a Brazilian sample.Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules.Effectiveness of Psychoeducational Group Training on Quality of Life and Recurrence of Patients with Bipolar Disorder.Closing the mental health treatment gap in South Africa: a review of costs and cost-effectiveness.Cost-effectiveness of asenapine in the treatment of patients with bipolar I disorder with mixed episodes in an Italian context.Mania: diagnosis and treatment recommendations.Economic evaluations in bipolar disorder: a systematic review and critical appraisal.Choosing cost-effective interventions in psychiatry: results from the CHOICE programme of the World Health OrganizationManagement of bipolar depressionStrengthening mental health systems in low- and middle-income countries: the Emerald programmeCost effectiveness of strategies to combat neuropsychiatric conditions in sub-Saharan Africa and South East Asia: mathematical modelling study.Adjunctive Behavioral Activation for the Treatment of Bipolar Depression: A Proof of Concept Trial.Asenapine: a review of its use in the management of mania in adults with bipolar I disorder.Evidence-based mental health care and implementation science in low- and middle-income countries.Development of the International Classification of Functioning, Disability and Health core sets for bipolar disorders: results of an international consensus process.A systematic and critical review of model-based economic evaluations of pharmacotherapeutics in patients with bipolar disorder.Psychoeducation for relapse prevention in bipolar disorder: a systematic review of efficacy in randomized controlled trials.A Systematic Review and Critical Appraisal of Economic Evaluations of Pharmacological Interventions for People with Bipolar Disorder.Cost-effectiveness of noninvasive ventilation for chronic obstructive pulmonary disease-related respiratory failure in Indian hospitals without ICU facilities.The prevalence and burden of bipolar disorder: findings from the Global Burden of Disease Study 2013.Perceptions of assertive community treatment in the UK and Lithuania.Societal economic costs and benefits from death: another look.Cost-effectiveness of the Mental Health and Development model for schizophrenia-spectrum and bipolar disorders in rural Kenya.Developing core sets for persons with bipolar disorder based on the International Classification of Functioning, Disability and Health.Mental health reform: Europe at the cross-roads.Cost-effectiveness of different clinical interventions for reducing the burden of schizophrenia in Spain.Implementing mental health economic evaluation evidence: Building a bridge between theory and practiceEconomics of Evidence-Based Practice and Mental Health
P2860
Q26861743-761390D9-1F26-4BCF-BF1C-F069AB654EE2Q27004676-2315F6C5-A62A-4C66-9E2C-AFE55242C8A8Q31037971-6DF1BAE4-7A0B-48D6-9625-5B5CF9721356Q33606843-B3103CA8-C9C9-456A-A31A-F231C227A689Q33658385-0667CD25-1EAF-4587-946C-F51187421F3BQ33686866-03C46D6E-7412-4DEE-9D5D-8F2B8FB3EB2DQ34100578-0FC5228B-9372-4777-AC9B-4E640F65D394Q34300315-A14B908E-99D6-4DE1-B5EA-C84A751B59A4Q34424079-FBFC744E-0139-46E3-91BA-2F3C3D558C99Q34482075-03DCDADF-5856-4234-ADB0-51B19C909D5BQ35365539-CCF6867C-40D3-4D44-8B1D-8B64EA92C101Q35369035-8FC2DC2A-9425-4E6C-939F-9C750654A1CFQ35798043-62D96F42-E7EC-4414-B312-EFCE845FDE4FQ36866555-9C487435-B489-4672-A7CF-9E1F98B5BF87Q37842439-22AD488F-DD5F-4BE3-A88B-7736372F31CAQ38026099-2D0B45F8-401D-4E2D-9C15-B6D7A3E660C7Q38099016-C5806E17-A25D-4050-8B31-1D7D616AAC7DQ38212591-795F2A0B-DCA8-4DC5-940E-C396EB10ABB0Q38320841-660DB07E-F487-4ADB-B59E-7DC9FC098F24Q38779921-18C75D47-20FE-416A-BF09-01EAAD4D3C1FQ38932306-7319B703-6D28-48DE-BAC6-AD1D86F5D782Q38938397-F3C0F8CE-E919-449C-A955-AC10C6071071Q40136092-88D157DE-CFCE-49EB-8B27-6590A127FE0AQ40231196-FA3D4BBE-660B-49AC-8BB2-835CDA967FF9Q41726287-830684F3-3D77-472B-9128-A5C8AAE2A3BBQ47578570-18124C4B-D71A-4BD9-A3A1-D475CE5BEF87Q51888335-C12508DB-8E5A-47B1-80B5-2C249C100555Q51910376-8309BCBD-488E-4911-BD20-83A2F5A5678EQ56020810-9282B9FE-C893-492F-B3C5-B82532540668Q58765776-0E30B260-DBCE-4C13-A837-29E5174CAA08
P2860
Cost-effectiveness of clinical interventions for reducing the global burden of bipolar disorder.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@en
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@nl
type
label
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@en
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@nl
prefLabel
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@en
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@nl
P2093
P356
P1476
Cost-effectiveness of clinical ...... al burden of bipolar disorder.
@en
P2093
Dan Chisholm
Jose-Luis Ayuso-Mateos
Mark van Ommeren
P304
P356
10.1192/BJP.187.6.559
P407
P577
2005-12-01T00:00:00Z